You are here GEAR Mind Maps References

References


  • Bucher, H. C., Guyatt, G. H., Griffith, L. E. and Walter, S. D. (1997) 'The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials', J Clin Epidemiol, 50(6), 683-91.
  • Carlson, M. D. A. and Morrison, R. S. (2009) 'Study Design, Precision, and Validity in Observational Studies', Journal of Palliative Medicine, 12(1), 77-82.
  • Cooper, N., Coyle, D., Abrams, K., Mugford, M. and Sutton, A. (2005) 'Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997', J Health Serv Res Policy, 10(4), 245-50.
  • Coyle, D., Lee, K. M. and Cooper, N. J. (2010) 'Use of Evidence in Decision Models' in Evidence-Based Decisions and Economics, Wiley-Blackwell, 106-113.
  • Cui, K., Li, X., Du, Y., Tang, X., Arai, S., et al. (2017) 'Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison', Oncotarget, 8(22), 36674-36684.
  • Deeks, J. J. (2002) 'Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes', Stat Med, 21(11), 1575-600.
  • Drummond, F., M., Sculpher, M. J., Claxton, K., Stoddart, G. L., et al. (2015) Methods for the Economic Evaluation of Health Care Programmes, Fourth Edition ed., Oxford university press.
  • Drummond, M., Augustovski, F., Kaló, Z., Yang, B.-M., Pichon-Riviere, A., et al. (2015a) 'CHALLENGES FACED IN TRANSFERRING ECONOMIC EVALUATIONS TO MIDDLE INCOME COUNTRIES', International Journal of Technology Assessment in Health Care, 31(6), 442-448.
  • European Food Safety Authority (2014) 'Guidance on Expert Knowledge Elicitation in Food and Feed Safety Risk Assessment', EFSA Journal, 12(6).
  • Garthwaite, P. H., Kadane, J. B. and O'Hagan, A. (2005) 'Statistical Methods for Eliciting Probability Distributions', Journal of the American Statistical Association, 100(470), 680-701.
  • Gartlehner, G. and Moore, C. G. (2008) 'Direct versus indirect comparisons: a summary of the evidence', Int J Technol Assess Health Care, 24(2), 170-7.
  • Glass, G. V. (1976) 'Primary, Secondary, and Meta-Analysis of Research', Educational Researcher, 5(10), 3-8.
  • Gomez, J. A., Tirado, J. C., Navarro Rojas, A. A., Castrejon Alba, M. M. and Topachevskyi, O. (2013) 'Cost-effectiveness and cost utility analysis of three pneumococcal conjugate vaccines in children of Peru', BMC Public Health, 13(1), 1025.
  • Goslin, J. P. (2014) 'Methods for eliciting expert opinion to inform health technology assessment', available: https://www.mrc.ac.uk/documents/pdf/methods-for-eliciting-expert-opinion-gosling-2014/ [Accessed October 12, 2016] 
  • Grigore, B., Peters, J., Hyde, C. and Stein, K. (2016) 'A comparison of two methods for expert elicitation in health technology assessments', BMC Medical Research Methodology, 16(1), 85.
  • Haasis, M. A., Ceria, J. A., Kulpeng, W., Teerawattananon, Y. and Alejandria, M. (2015) 'Do Pneumococcal Conjugate Vaccines Represent Good Value for Money in a Lower-Middle Income Country? A Cost-Utility Analysis in the Philippines', PLoS One, 10(7), e0131156.
  • Higgins, J. and Green, S. (2011) 'Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 ', [online], available: http://handbook.cochrane.org [Accessed March 2011].
  • Hsu, C.-C. and Sandford, B. A. (2007) 'The Delphi technique: making sense of consensus', Practical assessment, research & evaluation, 12.10, 1-8.
  • Jacobsen, K. H. (2016) Introduction To Health Research Methods: A Practical Guide  2nd Edition, Jones & Bartlett Learning.
  • Kim, S.-Y., Goldie, S. J. and Salomon, J. A. (2009) 'Cost-effectiveness of Rotavirus vaccination in Vietnam', BMC Public Health, 9(1), 29.
  • King, N. B., Harper, S. and Young, M. E. (2012) 'Use of relative and absolute effect measures in reporting health inequalities: structured review', BMJ : British Medical Journal, 345.
  • Kristiansen, I. S. and Gyrd-Hansen, D. (2004) 'Cost-effectiveness analysis based on the number-needed-to-treat: common sense or non-sense?', Health Econ, 13(1), 9-19.
  • Lewallen, S. and Courtright, P. (1998) 'Epidemiology in Practice: Case-Control Studies', Community Eye Health, 11(28), 57-58.
  • Mahajan, R. (2015) 'Real world data: Additional source for making clinical decisions', International Journal of Applied and Basic Medical Research, 5(2), 82-82.
  • Mann, C. J. (2003) 'Observational research methods. Research design II: cohort, cross sectional, and case-control studies', Emergency Medicine Journal, 20(1), 54-60.
  • Meeyai, A., Praditsitthikorn, N., Kotirum, S., Kulpeng, W., Putthasri, W., et al. (2015) 'Seasonal Influenza Vaccination for Children in Thailand: A Cost-Effectiveness Analysis', PLoS Med, 12(5), e1001829.
  • Meheus, F., Balasegaram, M., Olliaro, P., Sundar, S., Rijal, S., et al. (2010) 'Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent', PLOS Neglected Tropical Diseases, 4(9), e818.
  • Morton, S. C., Costlow, M. R., Graff, J. S. and Dubois, R. W. (2016) 'Standards and guidelines for observational studies: quality is in the eye of the beholder', Journal of Clinical Epidemiology, 71, 3-10.
  • Naing, C., Reid, S. A. and Aung, K. (2017) 'Comparing antibiotic treatment for leptospirosis using network meta-analysis: a tutorial', BMC Infectious Diseases, 17, 29.
  • O'Hagan, A., Buck, C. E., Daneshkhah, A., Eiser, J. R., Garthwaite, P. H., et al. (2006) Uncertain Judgements: Eliciting Experts' Probabilities, John Wiley & Sons.
  • Oakley, J. and O’Hagan, A. (2014) 'SHELF: the Sheffield Elicitation Framework (version 2.0). ', [online], available: http://tonyohagan.co.uk/ [Accessed October 13, 2016]
  • Ramsey, S. D., Willke, R. J., Augustovski, F., Briggs, A., Chan, W., et al. (2015) 'Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report', Value in Health, 18(161-72).
  • Roland, M. and Torgerson, D. J. (1998) 'Understanding controlled trials: What are pragmatic trials?', BMJ, 316(7127), 285.
  • Sackett, D. L., Rosenberg, W. M., Gray, J. A., Haynes, R. B. and Richardson, W. S. (1996) 'Evidence based medicine: what it is and what it isn't', BMJ, 312(7023), 71-2.
  • Salanti, G. (2012) 'Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool', Research Synthesis Methods, 3(2), 80-97.
  • Santatiwongchai, B., Chantarastapornchit, V., Wilkinson, T., Thiboonboon, K., Rattanavipapong, W., et al. (2015) 'Methodological Variation in Economic Evaluations Conducted in Low- and Middle-Income Countries: Information for Reference Case Development', PLOS ONE, 10(5), e0123853.
  • Schulz, K. F., Chalmers, I., Hayes, R. J. and Altman, D. G. (1995) 'Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials', JAMA, 273(5), 408-12.
  • Sormani, M. P. and Bruzzi, P. (2016) 'Estimating a treatment effect: Choosing between relative and absolute measures', Mult Scler.
  • Teerawattananon, Y., Mugford, M. and Tangcharoensathien, V. (2007) 'Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand', Value Health, 10(1), 61-72.
  • Thiboonboon, K., Santatiwongchai, B., Chantarastapornchit, V., Rattanavipapong, W. and Teerawattananon, Y. (2016) 'A Systematic Review of Economic Evaluation Methodologies Between Resource-Limited and Resource-Rich Countries: A Case of Rotavirus Vaccines', Appl Health Econ Health Policy, 14(6), 659-672.
  • Wang, T., Gou, Z., Wang, F., Ma, M. and Zhai, S.-d. (2014) 'Comparison of GLP-1 Analogues versus Sitagliptin in the Management of Type 2 Diabetes: Systematic Review and Meta-Analysis of Head-to-Head Studies', PLOS ONE, 9(8), e103798.